You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor Mutation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

Not yet recruiting
  • AXIN1 Gene Mutation
  • +2 more
  • (no location specified)
Aug 21, 2023

Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

Not yet recruiting
  • Solid Tumor
  • +4 more
  • (no location specified)
Feb 21, 2023

Pancreatic Cancer Trial in Seoul (cell free DNA in blood, genetic mutation in tissue)

Recruiting
  • Pancreatic Cancer
  • cell free DNA in blood, genetic mutation in tissue
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 2, 2022

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

Recruiting
  • Ovarian Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jul 13, 2022

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

    Recruiting
    • Advanced or Metastatic Solid Tumor
    • KRAS G12C Mutation
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Nov 2, 2023

    Bladder Cancer, Melanoma Trial in United States (Nivolumab, Nivolumab plus Ipilimumab)

    Active, not recruiting
    • Bladder Cancer
    • Melanoma
    • Farmington, Connecticut
    • +4 more
    May 9, 2022

    Advanced Solid Tumor, Metastatic Solid Tumor, NSCLCs Trial (PRT3789)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Fairfax, Virginia
      NEXT Virginia
    Feb 1, 2023

    Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

    Suspended
    • Solid Tumor
    • ARID1A Gene Mutation
    • Greenville, South Carolina
      Prisma Health Cancer Institute
    Jan 10, 2023

    NSCLC Trial in Shanghai (IN10018, Furmonertinib)

    Recruiting
    • NSCLC
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 8, 2023

    Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

    Recruiting
    • Metastatic Solid Tumor
    • +4 more
    • Recommendation for treatment with immunotherapy
    • Baltimore, Maryland
      Johns Hopkins University
    Sep 8, 2022

    Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

    Not yet recruiting
    • Cancer
    • +5 more
    • (no location specified)
    Aug 18, 2022

    Drug Sensitivity and Mutation Profiling

    Recruiting
    • Ewing Sarcoma
    • +6 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Aug 5, 2022

      Advanced Solid Tumor Trial in Shanghai (SY-5933)

      Recruiting
      • Advanced Solid Tumor
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Aug 16, 2023

      Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

      Recruiting
      • Advanced Solid Tumor
      • +3 more
      • Houston, Texas
      • +1 more
      Apr 14, 2023

      Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Jan 12, 2023

      PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

      Not yet recruiting
      • PIK3CA Mutation
      • +7 more
      • (no location specified)
      Mar 7, 2023

      Somatic Mosaicism in Twins Discordant for Childhood Cancer

      Not yet recruiting
      • Pediatric Central Nervous System Tumor
      • +3 more
      • Biospecimen collection
      • Questionnaire Administration
      • (no location specified)
      Sep 19, 2023

      Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

      Not yet recruiting
      • Solid Tumor, Adult
      • +4 more
      • (no location specified)
      Apr 24, 2023

      Advanced Solid Tumor Trial in Beijing (YK0901 cells)

      Not yet recruiting
      • Advanced Solid Tumor
      • YK0901 cells
      • Beijing, China
        Department of GI Oncology, Peking University Cancer Hospital
      Jun 27, 2023

      Advanced Solid Tumor Trial in Guangzhou (YL-17231)

      Recruiting
      • Advanced Solid Tumor
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Oct 5, 2023

      Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

      Recruiting
      • Refractory Cancer
      • +14 more
      • Atlanta, Georgia
      • +1 more
      Oct 23, 2023

      Women With BRCA1 Germline Deleterious Mutation Trial in France (Blood sampling)

      Completed
      • Women With BRCA1 Germline Deleterious Mutation
      • Blood sampling
      • Lyon, France
      • +3 more
      Jan 18, 2022

      OPTImal PALliative Anti-epidermal Growth Factor Receptor

      Active, not recruiting
      • Colorectal Cancer Metastatic
      • +5 more
      • Plasma circulating DNA analysis
      • Aarhus, Denmark
        Aarhus University Hospital
      Feb 24, 2022